Dutch consumer electronics giant Philips Electronics NV (PHGFF.PK, PHG) reported Monday that its fourth-quarter income from operations was 24 million euros, including charges of 363 million euros connected with the Respironics consent decree, which has been agreed with the US Department of Justice or DOJ, representing the US Food and Drug Administration.